Methylenedioxyamphetamine ('Ecstasy') associated keratopathy.
O'Neill
D
D
Dart
J K
JK
D015104:3,4-Methylenedioxyamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000293:Adolescent; D000328:Adult; D002701:Chloramphenicol / Q000627:therapeutic use; D003316:Corneal Diseases / Q000139:chemically induced* / Q000188:drug therapy; D015198:Designer Drugs / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine
D015198:Designer Drugs; D015104:3,4-Methylenedioxyamphetamine; D002701:Chloramphenicol; D018817:N-Methyl-3,4-methylenedioxyamphetamine